NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, will be hosting a conference call to discuss its corporate and financial results for the Fiscal Year ended 2018 and plans for upcoming fiscal year 2019.
"2018 was a year in which we diversified operations and made big investments in infrastructure and human capital that we believe will provide a foundation for strong future growth,” stated Justin Schreiber, President and CEO of Conversion Labs. “We look forward to discussing these 2018 achievements in more detail and our plans for growth in 2019 and beyond.”
2018 Financial and Strategic Highlights Include:
- Record Revenues in 2018: $8.324M in revenues, up 126% from 2017 revenues of $3.681M (excluding 2017 revenue from divested legacy manufacturing business)
- Focused and Diversified Product Portfolio: Expanded product portfolio to four commercial stage brands and sold off legacy manufacturing operations
- World Class Marketing Team: Continued to attract and invest in e-commerce executives with proven advertising expertise on Facebook, Google and Amazon
Conversion Labs will host a conference call on Wednesday, April 10 2019 at 4:15 PM Eastern Time to provide further details on 2018 results and to discuss plans for upcoming fiscal year 2019. The dial-in numbers for both domestic and international callers will be provided in a later press release and will be posted on the company’s investor relations page at ir.conversionlabs.com.
About Conversion Labs
Conversion Labs, Inc. (the "Company") is an e-commerce company with a portfolio of innovative and proprietary brands. Conversion Labs’ scalable and global advertising technology infrastructure leverages the world’s largest social media, search and e-commerce platforms (Facebook, Google & Amazon) to rapidly grow our continually expanding product portfolio. To learn more about our corporate strategy, brands or for investor relations please visit www.conversionlabs.com or email us at firstname.lastname@example.org.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates,” “plans,” or similar expressions or the negative of these terms and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause Conversion Labs, Inc.’s actual results to differ materially from those anticipated by the forward-looking statements. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell its products; the expected benefits and efficacy of the Company's products; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC.